Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products. Financial Results: Marksans Pharma Ltd reported Revenues for Q1FY24 of
Categories
Health Care
Wockhardt Ltd Q1FY24; 8% rise in Revenue
Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).
Pfizer Ltd Q1FY24; 185% rise in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Themis Medicare Ltd Q1FY24; 6% rise in Profits
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity. Financial Results:
TTK Healthcare Ltd Q1FY24; 97% fall in Profits
TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. It is a part
Zydus Lifesciences Ltd Q1FY24; 97% rise in Profits
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Nureca Ltd Q1FY24; 19% fall in Revenue
Nureca is a company engaged in the business of home healthcare and wellness products under the Brand "Dr. Trust". Co. sells its
Mangalam Drugs and Organics Ltd Q1FY24; 20% fall in Revenue
Mangalam Drugs & Organics Limited is engaged in manufacturing pharma APIs, Intermediates and Specialty Chemicals. Financial Results: Mangalam Drugs and Organics Ltd
Orchid Pharma Ltd Q1FY24; 40% rise in Revenue
Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It
Medico Remedies Ltd Q1FY24; 267% rise in Profits
Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations. Financial Results: Medico Remedies Ltd reported Revenues for Q1FY24 of ₹31.47
Sanofi India Ltd Q1FY24; 2% rise in Profits
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q1FY24
Shilpa Medicare Ltd Q1FY24; 50% fall in Profits
Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech
Lincoln Pharmaceuticals Ltd Q1FY24; 27% rise in Profits
Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products. Financial Results: Lincoln Pharmaceuticals Ltd
Vijaya Diagnostic Centre Ltd Q1FY24; 44% rise in Profits
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Natco Pharma Ltd Q1FY24; 31% rise in Profits
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products
Suven Pharmaceuticals Ltd Q1FY24; 12% rise in Profits
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. Financial
Shivalik Rasayan Ltd Q1FY24; 23% fall in Profits
The company is into manufacturing of agrochemicals and in 2015 it forayed into pharmaceuticals.The company acquired Medicamen Biotech Limited in 2015 which
Medicamen Biotech Ltd Q1FY24; 23% rise in Profits
Medicamen Biotech Ltd develops and markets a wide range of branded and generic formulations in the pharmaceutical industry. Financial Results: Medicamen Biotech
Suven Life Sciences Ltd Q1FY24; 0% equalled in Revenue
Suven Life Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialisation of novel therapeutics for the treatment
SMS Pharmaceuticals Ltd Q1FY24; 110% rise in Revenue
SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates. Financial Results: SMS
Windlas Biotech Ltd Q1FY24; 20% rise in Profits
Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid and liquid